XIAP gene therapy (AAV vector) (Neurologix)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameXIAP gene therapy (AAV vector) (Neurologix)
Drug Alias NameX-linked inhibitor of apoptosis gene therapy (adeno-associated virus vector) (Neurologix)
ClassificationBiologics
Mechanisms of ActionInhibitor of apoptosis protein 3 stimulants
TargetsInhibitor of apoptosis protein 3
Therapy Area/IndicationsHuntington Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNeurologix Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNeurologix Inc
Active IndicationsN/A
Inactive IndicationsHuntington Disease

Other Information

ATC CodeN/A
Related LinksN/A